Thermo Fisher Scientific (TMO) Receivables (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Receivables for 18 consecutive years, with $10.9 billion the latest figure, recorded in Q1 2026.

• Receivables for Q1 2026 came in at $10.9 billion, up 10.86% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.9 billion (up 10.86% YoY), and the FY2025 annual result was $10.6 billion, up 9.77% from the prior year.
• Receivables was $10.9 billion for Q1 2026 at Thermo Fisher Scientific, up from $10.6 billion in the prior quarter.
• Over five years, Receivables peaked at $10.9 billion in Q1 2026 and troughed at $8.9 billion in Q3 2022.
• Average Receivables over 5 years is $9.7 billion, with a median of $9.6 billion recorded in 2024.
• Year-over-year, Receivables soared 41.59% in 2022 and fell 0.59% in 2024.
• Over 5 years, Receivables stood at $9.4 billion in 2022, then rose by 2.51% to $9.7 billion in 2023, then retreated by 0.39% to $9.6 billion in 2024, then increased by 9.77% to $10.6 billion in 2025, then increased by 3.05% to $10.9 billion in 2026.
• Per Business Quant data, the three most recent Receivables figures were $10.9 billion in Q1 2026, $10.6 billion in Q4 2025, and $10.5 billion in Q3 2025.